Dominique Hansen, PhD, FESC

Slides:



Advertisements
Similar presentations
CONTROLLING YOUR RISK FACTORS Taking the Steps to a Healthy Heart.
Advertisements

10 Points to Remember for the Management of Overweight and Obesity in Adults Management of Overweight and Obesity in Adults Summary Prepared by Elizabeth.
Cardio-Metabolic Syndrome Guidelines on Education, Detection and Early Treatment  Heval Mohamed Kelli, PGY-2 Emory Internal Medicine Residency no conflict.
THE ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES STUDY (ACCORD)
ABSTRACT CONCLUSIONS BACKGROUND Heart Rate Recovery: An Indicator of Fitness Among Middle School Children Daniel Simhaee, Roopa Gurm, Susan Aaronson, Jean.
Effectiveness of interactive web-based lifestyle program on prevention of cardiovascular diseases risk factors in patient with metabolic syndrome: a randomized.
BHS Guidelines for the management of hypertension BHS IV, 2004 and Update of the NICE Hypertension Guideline, 2006 Guidelines for management of hypertension:
Module 2 – Foundations of Training (2) Heart Rate and Heart Rate Monitors 1 Sports Performance 25.
Minimally Invasive Surgery Symposium Modest Weight Loss in T2 DM: Lessons from the Look AHEAD Trial Donna H. Ryan, MD Pennington Biomedical Research Center.
{ A Novel Tool for Cardiovascular Risk Screening in the Ambulatory Setting Guideline-Based CPRS Dialog Adam Simons MD.
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
Chapter 3 Health Appraisal. Evaluating Health Status Categories M edical history review R isk factor assessment and stratification P rescribed medications.
Effect of exercise in treatment of obesity T.Ahadi MD Gr.Raissi MD Assistant professor of physical medicine and rehabilitation.
The effects of initial and subsequent adiposity status on diabetes mellitus Speaker: Qingtao Meng. MD West China hospital, Chendu, China.
AN ASSESSMENT OF THE PRIMARY PREVENTION CONTROL PROGRAM OF PHC PREVENTIVE CARDIOLOGY CLINIC AMONG PATIENTS AT RISK FOR CVD: A Retrospective Cohort Study.
Effect of Hypertension and Dyslipidemia on glycemic control among Type 2 Diabetes patients in Thailand Dr. Mya Thandar Dr.PH. Batch 5 1.
Kotseva K, et al. Eur J Cardiovasc Prev Rehabil 2009 Mar 12 [Epub]
VA/DoD 2006 Clinical Practice Guideline For Screening and Management of Overweight and Obesity Guideline Summary: Key Elements.
A MODERATE-INTENSITY EXERCISE PROGRAM, FULFILLING THE ACSM NET ENERGY EXPENDITURE RECOMMENDATION, IMPROVES HEALTH OUTCOMES IN PREMENOPAUSAL WOMEN Borresen,
CV Exercise Prescription. Reasonable and Expected Values for VO 2 Category or Level ml. kg -1 min -1 ml. min -1 METS Male (75 kg) Female (60 kg) Male.
Effect of Hypertension and Dyslipidemia on glycemic control among Type 2 Diabetes patients Dr. Mya Thandar.
HDL LowLess than 40 mg/dL High60 mg/dL and above LDL OptimalLess than 100 mg/dL Near Optimal mg/dL Borderline High mg/dL High mg/dL.
Cardiovascular Disease Risk Stratification
Heart rate in heart failure: Heart rate in heart failure: risk marker or risk factor? A subanalysis of the SHIFT trial on behalf of the Investigators M.
Physical Fitness and You. Physical Benefits of Exercise Improves Cardiovascular Fitness Improves Cardiovascular Fitness Controls Weight Controls Weight.
Monitoring Physical Health Stephen R. Marder, M.D. Professor, Semel Institute for Neuroscience and Human Behavior at UCLA Director, VA VISN 22 Mental Illness.
Exercise and adult women’s health Amos Pines. Be fit – be healthy Be fit – be healthy Ordinary exercise testing Walk test Ways to measure fitness: Parameters.
Case 1: Elevated LDL-C in a Young Adult. Page 2 of 10 *DALY; disability-adjusted life years Routine checkup:  Age:33 years  Sex: male  Status: Except.
The EACPR EXPERT flowchart programme : a tool to prescribe exercise training in the setting of cardiac rehabilitation Dominique Hansen, PhD, FESC Hasselt.
PRECISION-ABPM Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen Ambulatory Blood Pressure Measurement Trial.
The EAPC Exercise Prescription in Everyday Practice & Rehabilitation Training (EXPERT) tool – a digital decision support system for optimize exercise prescription.
Dominique Hansen, PhD, FESC
An analysis of 22,672 patients from the CLARIFY registry
CAD Exercise Adaptations
The EXPERT tool: focus on prevention
R.C. Sullivan & S.N. Meadows Waist Circumference (cm)
a cautionary note from SPRINT
a cautionary note from SPRINT
ACCORD Design and Baseline Characteristics
Baseline characteristics and effectiveness results
EXERCISE PRESCRIPTION FOR MY CLIENT.
Peak oxygen uptake and prevalence of cardiovascular disease risk factors in breast cancer survivors Lahart1, I.M., Metsios1, G.S., Nevill1, A.M., Kitas1,2,
Contemporary health challenges. How can physiotherapy have an impact
Cardiorespiratory Endurance
Exercise therapy in type 2 diabetes: state of the art
Prevalence and control of cardiovascular risk factors using a German sample – Findings from the STAAB Cohort Study Theresa Tiffe1,3, Götz Gelbrich1,2,
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults Risks and Assessment NHLBI Obesity Education.
Sunjoo Boo, RN, PhD, Erika Sivarajan Froelicher, RN, PhD, FAAN 
Diabetes Health Status Report
Individualized physical training in CV prevention and rehabilitation
WHI Observational Study: Cardiovascular death in women with hypertension but no history of CVD on monotherapy CVD death Diuretic, HR (95% CI) ACE inhibitor,
Exercise prescription in cardiovascular disease: guidelines vs
1 Physical Activity, Health, and Chronic Disease chapter 1 chapter
No conflict of interest
Prescription of strength training for cardiac rehabilitation
Sunjoo Boo, RN, PhD, Erika Sivarajan Froelicher, RN, PhD, FAAN 
Optimizing exercise prescription: EXPERT tool
Level of risk factor control in the overall sample and by gender
Dominique Hansen, PhD, FESC Hasselt University
5 COMPONENTS OF HEALTH-RELATED FITNESS
Systolic Heart failure treatment with the If inhibitor ivabradine Trial Effect of ivabradine on recurrent hospitalization for worsening heart failure:
Goals & Guidelines A summary of international guidelines for CHD
Train-the-Trainer Cases
Train-the-Trainer Cases
Dominique Hansen, PhD, FESC
Train-the-Trainer Cases
Section 6: Update on lipid treatment guidelines
HR for mortality in ischemic heart disease.
The benefits: exercise and cardiometabolic disease
HR for myocardial infarction.
Presentation transcript:

Dominique Hansen, PhD, FESC The EXPERT-Tool: a digital decision support system for integrated state-of-the-art exercise prescription in CVD Dominique Hansen, PhD, FESC

Disclosure statement None to be declared

Exercise in cardiovascular disease: guidelines Piepoli MF, et al. Eur J Prev Cardiol 2016;23:NP1-96

But how good are we in lowering cardiovascular disease risk by exercise intervention?

Impact of exercise intervention on CVD risk Risk factor Primary prevention Secondary prevention Fat mass SBP DBP HDL LDL TC HbA1c (in diabetes) VO2peak Chen YC, et al. Eur J Cardiovasc Nurs. 2017: 16: 397-408 Pattyn N, et al. Sports Med. 2013; 43: 121-33.

Importance of optimal CV risk management

for exercise prescription

Tailor your intervention We should aim for maximum improvement of the CVD risk, but with optimal medical safety, to prevent cardiovascular disease Tailor your intervention

Approach in tailoring exercise Patient phenotype Prevalent CV disease CVD risk profile Blood lipid profile Glycemic control Fat mass

But what about different combinations of CVD risk factors? How good are we in prescribing exercise in these patients?

Compare exercise prescriptions from different clinicians to the same (complex) patient and observe …whether they agree between themselves …whether they agree with guidelines

Comparing different clinicians

Comparing different clinicians Hansen D, et al. Eur J Prev Cardiol 2018; 25: 682-91

Comparing different clinicians Hansen D, et al. Eur J Prev Cardiol 2018; 25: 682-91

Comparing different clinicians Hansen D, et al. Eur J Prev Cardiol 2018; 25: 682-91

A gap is present between… Clinical practice Guidelines

Hansen D, et al. Eur J Prev Cardiol 2017; 24: 1017-31 Hansen D, et al. Eur Heart J 2017; 38: 2318-20

EXPERT Tool Digital, interactive decision support tool for exercise prescription Endorsed by the European Association of Preventive Cardiology Access: https://expert-tool.edm.uhasselt.be License: www.escardio.org/Education/Practice-Tools/CVD-prevention-toolbox/expert-tool

EXPERT tool Hansen D, et al. Eur J Prev Cardiol 2017; 24: 1017-31

EXPERT tool Hansen D, et al. Sports Med 2018; e-pub ahead of print, doi: 10.1007/s40279-018-0930-4

as a recommendation tool for the professional EXPERT tool as a recommendation tool for the professional as an educational tool in university as a training tool in a hospital / rehab center integrated with a mobile patient app (e.g. HeartHab app UHasselt) -> S. Sankaran, et al.

EXPERT tool Hansen D, et al. Eur J Prev Cardiol 2017; 24: 1017-31

EXPERT tool

EXPERT tool

EXPERT tool

EXPERT tool

Simulations of exercise prescription Age: Body height: Body weight: BMI: Sex: VO2max: Resting HR: Peak exercise HR: Total cholesterol: LDL: Fasting glycaemia: Blood pressure: Medication intake: Co-morbidities: 61 years 170 cm 97 kg 33.56 kg/m² Male 2283 ml/min (100% of normal value) 69 bpm 141 bpm ? 125/80 mmHg Beta blocker, ACE inhibitor, Antiplatelet none

Tool starts with regular exercise prescription EXPERT simulation Tool starts with regular exercise prescription 150 min low-to-moderate intense endurance exercise training per week (spread over 3-5 days, achieving 1000-2000 kcal) for at least 12 weeks But further adjusts: Intake of diuretics, betablockers, ACE inhibitor Patient is thus hypertensive Elevate exercise frequency, consider hand grip strength exercises Obesity Maximize caloric expenditure Prolong intervention

EXPERT output EXPERT simulation Exercise prescription: Intensity: HR 98-111 bts/min Frequency: build up to at least 5 days/week Exercise session duration: from 30 up to 60 min/session Minimal program duration: >24 weeks Strength training: yes Consider hand grip strength exercises

EXPERT simulation Age: Body height: Body weight: BMI: Sex: VO2max: Resting HR: Peak exercise HR: Total cholesterol: LDL: Fasting glycaemia: Blood pressure: Medication intake: Co-morbidities: 61 years 170 cm 97 kg 33.56 kg/m² Male 1283 ml/min (65% of normal value) 69 bpm 141 bpm ? 125 mg/dl 125/80 mmHg Beta blocker, ACE inhibitor, Antiplatelet, Metformin none

Intake of diuretics, betablockers, ACE inhibitor EXPERT simulation Intake of diuretics, betablockers, ACE inhibitor Patient is thus hypertensive Elevate exercise frequency, consider hand grip strength exercises Obesity Maximize caloric expenditure Prolong intervention But further adjusts: Low VO2peak Start at lower intensity Type 2 diabetes Elevate exercise frequency, add strength training, prolong intervention

EXPERT output EXPERT simulation Exercise prescription: Intensity: HR 90-98 bts/min Frequency: build up to at least 5 days/week Exercise session duration: from 30 up to 60 min/session Minimal program duration: >24 weeks Strength training: yes Consider hand grip strength exercises Strength training for large muscle groups

Exercise intervention is potent to improve CVD risk Conclusions Exercise intervention is potent to improve CVD risk However, there is room for further improvement The variance in exercise perscriptions between clinicians is too large The EXPERT tool may be of clinical assistance

Members of EXPERT working group Colleagues of EDM from Hasselt university Prof. dr. Karin Coninx & dr. Gustavo Rovelo Ruiz Members of EXPERT survey working group